Wednesday, January 30, 2019 10:56:42 PM
@ 11:40
Anyone think the CFO, John Vasha is on the team to add another 100M USD deal onto his resume?
I'd bet John Vasha and the rest of the board is eyeballing @ minimum 1B USD valuation.
Jim Hutchens went further to illustrate/opine about the recent buyout of Novadaq by Stryker for 700M USD.
https://www.fiercebiotech.com/medtech/stryker-to-pony-up-700m-for-imaging-player-novadaq
Folks, It's not hard to understand that Novadaq's imaging technology is inferior to that of Imagin Medical.
Therefore, given all that I've come to know, understand, and most importantly believe to be true, I'll make my prediction known right now:
$5 USD price target @ IMEXF within 12 months.
/////AMG
P.S. It's one thing to read a presentation posted to a corporate website from the comfort of your home. It's an entirely different thing when the President & CEO of the company (Jim Hutchens) steps onto the world stage and stakes a claim to being the cutting edge Top Dog in the industry. The official coming out party aimed at the largest medical device market on the planet - USA. Imagine That
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM